Buprenorphine
-
Subject Areas on Research
- A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.
- Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
- Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
- Assessment of postoperative analgesia after application of ultrasound-guided regional anesthesia for surgery in a swine femoral fracture model.
- Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.
- Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active.
- Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
- Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
- Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.
- Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.
- Curious Crosses: Injection-Induced Lesions.
- Digital ischaemia after intra-arterial drug injection.
- Effect of pain management on immunization efficacy in mice.
- Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
- Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina.
- Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder.
- HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.
- High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.
- Increasing collaboration on substance use disorder research with primary care practices through the National Drug Abuse Treatment Clinical Trials Network.
- Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression.
- Medication-Based Treatment to Address Opioid Use Disorder.
- Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
- Opioid Management in Pregnancy and Postpartum.
- Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study.
- Opioid use disorder deaths and the effects of medication therapy.
- Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
- P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.
- Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.
- Pharmacokinetic interactions between buprenorphine and antiretroviral medications.
- Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine.
- Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality.
- The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
- Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.
- Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.
- Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone.
-
Keywords of People
- Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine